Skip Navigation LinksHome > August 2014 - Volume 20 - Issue 8 > Long-term Comparative Efficacy of Cyclosporine- or Inflixima...
Inflammatory Bowel Diseases:
doi: 10.1097/MIB.0000000000000101
Original Clinical Articles

Long-term Comparative Efficacy of Cyclosporine- or Infliximab-based Strategies for the Management of Steroid-refractory Ulcerative Colitis Attacks

Naves, Juan E. MD*,†; Llaó, Jordina MD†,‡; Ruiz-Cerulla, Alexandra MD§; Romero, Cristina MD; Mañosa, Míriam MD, PhD*; Lobatón, Triana MD§; Cabré, Eduard MD, PhD*; Garcia-Planella, Esther MD; Guardiola, Jordi MD§; Domènech, Eugeni MD, PhD*

Collapse Box

Abstract

Background:

The short-term efficacy of infliximab (IFX) and cyclosporine A (CsA) in steroid-refractory ulcerative colitis (SRUC) has been recently shown to be similar, but long-term outcomes are still unclear. Moreover, the need for further rescue therapies in patients treated with IFX or CsA for SRUC has not been reported. The aims of our study were to compare short-term and long-term efficacy between 2 different strategies based on initial treatment with CsA or IFX for SRUC attacks.

Patients and Methods:

Between January 2005 and December 2011, all patients admitted for SRUC who required medical rescue therapy were identified from the electronic databases of 3 referral centers and grouped according to whether they received CsA or IFX as first-line rescue therapy, and retrospectively reviewed.

Results:

Among 50 SRUC attacks, 20 were treated with CsA as first-line rescue therapy and 30 with IFX. The CsA group had a higher proportion of patients with severe UC activity immediately before rescue therapy (P = 0.03) and a shorter median time from intravenous corticosteroids to rescue therapy (P = 0.03). A higher proportion of patients in the CsA group received second-line drug therapy (switch) as compared with the IFX group (P = 0.04). Fifteen patients (30%) were colectomized during the study period, with no between-group differences. Previous thiopurine exposure (P = 0.004; odds ratio = 6.1 [1.7–20.9]) was the only independent predictor of colectomy.

Conclusions:

CsA- and IFX-based strategies for SRUC seem similarly effective in preventing colectomy in the short and long term, although second-line drug therapy is more often required with CsA-based strategies.

Copyright © 2014 Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.